TCMDAugust 10, 2026 at 10:56 PM UTCHealth Care Equipment & Services

Tactile Systems (TCMD) Crushes Q2 Estimates, Strengthening Bull Case

Read source article

What happened

Tactile Systems Technology reported Q2 earnings of $0.34 per share, shattering the Zacks Consensus Estimate of $0.14 and more than doubling the prior year's $0.14. The beat was driven by continued strong demand for its lymphedema and respiratory devices, underscoring the resilience of its direct-to-patient model and broad reimbursement coverage. This performance comes as the company’s next-generation Nimbl platform ramps up, a key growth catalyst flagged in the DeepValue master report. With $26.6 million in aggressive buybacks already executed in the first half of 2025, management is signaling confidence in intrinsic value far above the current ~$14 market price. Despite risks from Medicare Advantage utilization controls, the earnings surprise and favorable policy tailwinds reinforce the thesis that TCMD is deeply undervalued relative to a DCF estimate near $90.

Implication

The substantial earnings beat provides concrete evidence that Tactile’s commercial engine is firing on all cylinders, with the direct-to-patient model capturing demand despite broader macro headwinds. It also supports the view that Nimbl’s staged launch is beginning to contribute, potentially accelerating in the second half of 2025. The confidence signaled by the $26.6 million in buybacks reinforces that management sees the stock as deeply undervalued, aligning with the DCF-derived intrinsic value of ~$90. While Medicare Advantage documentation and non-pneumatic competitor pressures remain, the near-term results suggest those risks are more than priced in. For investors, the beat and buyback activity provide a margin of safety and signal that the market may finally be starting to recognize Tactile’s value.

Thesis delta

The Q2 beat does not alter the underlying BUY thesis but materially reinforces it, confirming execution is on track and reducing downside risk. With no change to the Nimbl catalyst, aggressive buybacks, or policy tailwinds, the investment case remains intact and the undervaluation appears even more pronounced.

Confidence

High